Impact BioMedical Inc.
IBO | AMEX
$3.80
-$0.07 (-1.81%)
At close: Oct 30, 2026, 4:00 PM ET
$3.80
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.33 | -210.16 | -38.28 | -4.39 | -4.39 | -51.64 |
PEG Ratio | 0 | 2.33 | 0.43 | n/a | 0 | n/a |
PS Ratio | 497.66 | n/a | n/a | 616.25 | 616.25 | n/a |
PB Ratio | 1.26 | 14.22 | 6.40 | 1.04 | 0.84 | 0.81 |
P/FCF Ratio | -8.43 | -10.74 | -56.28 | -12.24 | -12.24 | -34.31 |
P/OCF Ratio | -8.43 | -10.74 | -56.63 | -13.74 | -13.74 | -34.31 |
OCF/S Ratio | -5.91K | n/a | n/a | -4.48K | -4.48K | n/a |
Debt / Equity Ratio | n/a | 2.08 | 0.48 | 0.34 | 0.34 | 0.03 |
Quick Ratio | 0.30 | 0.25 | 0.03 | 0.01 | 0.02 | 0.10 |
Current Ratio | 0.35 | 0.25 | 0.03 | 0.01 | 0.02 | 0.10 |
Asset Turnover | 0 | n/a | n/a | 0 | 0 | n/a |
Interest Coverage | -5.38 | -244.91 | -9.07 | -7.37 | -11.35 | n/a |
Return on Equity | -93.89% | -580.14% | -17.19% | -23.85% | -19.26% | -1.58% |
Return on Assets | -68.01% | -121.77% | -9.71% | -15.16% | -12.50% | -1.24% |
Return on Invested Capital | -21.59% | -148.34% | -9.24% | -6.83% | -5.57% | -1.69% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -1.23K% | n/a | n/a | 100% | 100% | n/a |
Net Profit Margin | -36.99K% | n/a | n/a | -14.1K% | -14.1K% | n/a |
Pretax Profit Margin | -45.16K% | n/a | n/a | -15.75K% | -15.75K% | n/a |
Operating Profit Margin | -13.34K% | n/a | n/a | -6.81K% | -6.81K% | n/a |
FCF Margin | -5.91K% | n/a | n/a | -5.04K% | -5.04K% | n/a |
EBITDA Margin | -39.1K% | n/a | n/a | -12.6K% | -12.6K% | n/a |
Add to Watchlist
Select watchlists to add or remove IBO